Parteck® Functional Excipients

Tableting formulation

When you design a solid dosage form, there are many factors to consider: the active ingredient, bioavailability enhancement, release kinetics, specific dosage, packaging, shelf life, and more.

Our Parteck® excipients were designed with the formulator’s challenges in mind and are particle optimized for excellent performance in formulation development and manufacture. Backed by the Emprove® Program with its stringent quality control, as well as regulatory support and documentation, Parteck® excipients help to speed up your approval processes.

Flexible Tableting

  • High tablet hardness at low compression forces, providing tablet robustness and rapid disintegration
  • High and low API dosages enabled by the unique particle surface
  • Specialized excipients for direct compression, wet and dry granulation, film coating, lubrication, and rapid disintegration

White Paper: API Stability in Solid Dose Formulation – Exploring the Myth of Inert Excipients

Webinar: Continuous Manufacturing in Solid Dose – How to Leverage Opportunities of this New Technology

Webinar: Coating with Polyvinyl Alcohol: When Coating Runs Smoothly

Webinar: Total Cost of Ownership – How the Choice of Excipients Makes your Economics

Optimized Drug Delivery

  • Options for modifying release kinetics, such as orally disintegrating tablets and sustained-release solid oral formulations
  • Specialized excipients for different routes of administration, including dry powder inhalation

White Paper: New Opportunities for Oral Sustained Release Formulations with Polyvinyl Alcohol

White Paper: Considerations for Dosing Accuracy in a New Carrier for Dry Powder Inhalation

Webinar: PVA for Sustained Release: Theory and Practice

Enhanced Solubility

  • Specialized excipients that boost the efficacy of your final drug product by enhancing API solubility through the use of polyvinyl alcohol for hot melt extrusion, or a silica drug carrier with a unique surface structure

Webinar: Hot Melt Extrusion with PVA ‐ A New Opportunity for Challenging APIs

Webinar: Solubility Enhancement, Stability and Scalability of Mesoporous Silica Formulations: from Lab to Production Scale




Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.